Skip to content

LegitScript Identifies Merchants Marketing Supplements as Drugs Following FDAs Warning Against Fraudulent Flu Products

Pills on a computer keyboard

The US Food and Drug Administration (FDA) recently released a consumer update warning against fraudulent flu products on the market in 2022-2023 flu season. LegitScript has identified websites that appear to be marketing homeopathic products and dietary supplements claiming to treat or cure seasonal flu. Keep reading to understand the FDA’s warning and some problematic claims made by these products.

Some Fraudulent Flu Products Use Problematic Marketing — Prompting FDA Warning Letters

According to the FDA, if “a product is intended to treat, diagnose, cure, or prevent diseases, it is a drug, even if it is labeled as a dietary supplement.” The FDA actively pursues companies misbranding supplements and over-the-counter products.

Merchants making false drug claims may face a warning letter. In an October 2022 letter issued to Rosebud's Ranch and Garden, LLC, the administration pointed to impermissible claims on the merchant’s website and social media accounts about their tea products’ ability to treat the flu and other diseases.

Some of these claims, according to the warning letter, included:

  • “Eases the discomfort of a cold or flu”
  • “Eases Muscular Pain”
  • “Cancer Preventer”
  • “Blood Sugar Balancer”
  • “lowering bad cholesterol”

The letter stated that the “claims on your websites establish the products are drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 321(g)(1)(B)] because they are intended for use in the cure, mitigation, treatment, or prevention of disease.”

In the course of our monitoring work, LegitScript has identified websites marketing dietary supplements, vitamins, and herbs with claims they increase immunity and reduce the symptoms of upper respiratory illnesses like the flu.

LegitScript uncovered fraudulent flu products.

A website known to LegitScript markets an “Anti-Viral Immunity Booster” dietary supplement with language that claims it treats respiratory infections, viral fever, seasonal flu, COVID-19, and more.

Products Marketed Problematically May Include These Types of Claims

The FDA has warned consumers to look out for potentially fraudulent flu and antiviral products being sold without a prescription. Such products may claim to:

  • Reduce the severity and length of flu or other viral infections
  • Boost your immunity naturally without a flu vaccine
  • Act as a safe and effective alternative to the flu vaccine
  • Prevent catching the flu or viral infections
  • Be an effective treatment for flu or viral infections
  • Provide faster recovery from the flu or viral infections
  • Support your body’s natural immune defenses to fight off flu or other viruses
  • Want to Learn More About How To Correctly Advertise Supplements Online?

Are you a supplement seller, or do you process payments for supplement merchants? Our comprehensive guide The Dos and Don’ts of Internet Supplement Ads sheds light on common compliance issues supplement merchants face every day. Topics covered include everything from sponsored content and endorsements to user experience and popups. Click the image or button below to download your free guide today.

cover of supplement marketing gudie showing a pile of viatmins and supplements.

Smelting words into a specialty since 2020, Thea Le Fevre specializes in B2B SaaS Content Marketing. Take a deep dive into her work for up-to-date industry news surrounding issues in payments risk & compliance, trust & safety, regulatory compliance, and more.

Recent Blog Articles

From Shortage Heroes to Compliance Champions: What Today’s GLP-1 Pharmacies Must Know

The GLP-1 regulatory landscape has shifted for compounding pharmacies and understanding the current environment is essential for the health of these businesses. If your business offers compounded versions of semaglutide or tirzepatide, you are operating in a regulatory environment that has changed d...

Merchant Onboarding in the Age of AI: Key Takeaways from the LegitScript Webinar

The risk landscape for underwriting and onboarding is getting more complex by the day as the technological waves that drive innovation are also arming bad actors with new tools. In our webinar "Merchant Onboarding Best Practices for an AI-Powered Future," expert panelists offered a pragmatic look at...

Merchant Onboarding: Frequently Asked Questions

Merchant Monitoring Resource Center Types of Payments Risk Expand What Are High-Risk Verticals? What are BRAM and VIRP fines? What Is Transaction Laundering? Money Laundering vs. Transaction Laundering What is PCI compliance? Why Is Reputational Protection Important in Payments? Monitoring and Risk...

Tainted Nutraceuticals: Hidden Ingredients, Real Risks

Merchants are facing increasing scrutiny for selling nutraceuticals tainted with harmful ingredients, which are often undeclared on product labels. This poses a challenge to payment processors trying to keep their portfolios free of dangerous products and increases the risk of card network violation...